-
公开(公告)号:US20070122491A1
公开(公告)日:2007-05-31
申请号:US11581282
申请日:2006-10-16
申请人: Thomas Lyons , Ronan Power
发明人: Thomas Lyons , Ronan Power
IPC分类号: A61K38/28 , A61K38/22 , A61K33/26 , A61K33/04 , A61K31/426 , A61K31/155 , A61K31/17
CPC分类号: A61K33/04 , A61K31/155 , A61K31/17 , A61K31/426 , A61K33/24 , A61K38/28 , A61K45/06 , A61K2300/00 , A61K33/28
摘要: The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.
摘要翻译: 本发明涉及用于改变细胞功能的组合物和方法。 特别地,本发明提供了包含硒(例如SEL-PLEX)的组合物及其使用方法(例如,作为神经变性疾病的治疗和/或预防性治疗)。 另外,本发明证明硒的特定形式(例如,SEL-PLEX)具有改变与疾病和/或衰老相关基因表达的能力,而其他形式的硒(例如硒代甲硫氨酸)不具有这种能力。